Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Evaluation of an Antihypertensive Food Supplement Based on Aqueous Extract From Annona Muricata Sheets [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating an antihypertensive food supplement derived from Annona muricata aqueous extract; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Annona muricata aqueous extract antihypertensive supplement

Snippet

Sponsor: Yaounde Central Hospital | Conditions: Hypertension | Phase 2, Phase 3 | Status: COMPLETED